NCT02348775
|
2014-11-01 |
Glutathione and Function in HIV Patients
|
Phase 1
|
Recruiting
|
NCT02348762
|
2014-11-01 |
Energetics and Function in Older Humans
|
Phase 1
|
Recruiting
|
NCT02064881
|
2014-06-01 |
Efficacy Study of Metformin Glycinate on Postprandial Lipemia
|
Phase 2/Phase 3
|
Not Yet Recruiting
|
NCT02108691
|
2014-05-01 |
Effect of Intake of Glycin Max (L.) Merr. Peel Extract on Body Fat and Body Weight
|
Phase 2/Phase 3
|
Not Yet Recruiting
|
NCT02128971
|
2014-04-01 |
A Study to Compare the Gastrointestinal Tolerability of FerrochelĀ®, SumalateĀ®,Ferrous Fumarate, Ferrous Sulfate, Ferric Glycinate, and Placebo
|
Phase 2
|
Recruiting
|
NCT01720316
|
2012-12-01 |
Neurobiology of a Mutation in Glycine Metabolism in Psychotic Disorders
|
Phase 2
|
Enrolling By Invitation
|
NCT01417481
|
2012-03-01 |
Effect of Glycine in Cystic Fibrosis
|
Phase 2
|
Terminated
|
NCT01501942
|
2012-02-01 |
Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Oral Administration of AIM-102 in Patients With Mild to Moderate Allergic Asthma
|
Phase 2
|
Completed
|
NCT01560481
|
2011-12-01 |
Clinical Trial to Evaluate Safety and pK Profile of Metformin Glycinate in Healthy Volunteers
|
Phase 1
|
Completed
|
NCT01386671
|
2011-08-01 |
Metformin Glycinate on Metabolic Control and Inflammatory Mediators in Type 2 Diabetes
|
Phase 3
|
Active, Not Recruiting
|
NCT01425463
|
2011-03-01 |
A Double-blind, Double-dummy, Parallel, Active-controlled, Randomized Trial to Evaluate Efficacy & Safety in Anemia Subjects
|
Phase 3
|
Completed
|
NCT01913808
|
2011-01-01 |
Comparing Intravenous and Oral Iron in Postoperative Anemia
|
Phase 4
|
Completed
|
NCT01355198
|
2010-08-01 |
Role of HIV on Glutathione Synthesis and Oxidative Stress
|
Phase 1
|
Completed
|
NCT01116310
|
2010-04-01 |
Clinical Trial to Evaluate the Efficacy of FITOGYN Versus Placebo on the Vasomotor Symptomatology Associated With Menopause
|
Phase 4
|
Recruiting
|
NCT00913692
|
2009-06-01 |
A Randomized Double-Blind Control-Comparison Crossover Trial of Oral Glutamine to Suppress Frequently Recurrent Herpes Labialis
|
Phase 2
|
Terminated
|
NCT00929370
|
2008-07-01 |
A Repeat Dose Study With GSK1018921 to Assess Safety, Tolerability, Pharmacokinetics, Pharmacodynamics in Healthy Volunteers and Patients With Schizophrenia and to Evaluate Its Effect on PK of Midazolam.
|
Phase 1
|
Terminated
|
NCT00575848
|
2007-12-01 |
Study of the Effects of Glycine on Symptoms and Memory in Patients With Schizophrenia
|
Phase 1
|
Terminated
|
NCT01031927
|
2007-06-01 |
N-methyl Glycine (Sarcosine) for the Treatment of Obsessive Compulsive Disorder (OCD)
|
Phase 2
|
Completed
|
NCT00133406
|
2006-06-01 |
Long-term Impact and Intervention for Diarrhea in Brazil
|
Phase 3
|
Recruiting
|
NCT00291226
|
2006-03-01 |
Glycine vs Placebo for the Schizophrenia Prodrome
|
Phase 2/Phase 3
|
Completed
|
NCT00133562
|
2004-08-01 |
HIAS II - Study of Nutritional Supplementation in Hospitalized Children With Persistent Diarrhea or Malnutrition
|
Phase 3
|
Withdrawn
|
NCT00338221
|
2004-08-01 |
Clinical Trial of Alanyl-Glutamine or Glycine in Children With Persistent Diarrhea or Malnutrition
|
Phase 3
|
Withdrawn
|
NCT00338598
|
2003-06-01 |
Facilitation of NMDA Receptor Function in Patients With Schizophrenia and Co-morbid Alcoholism
|
Phase 2
|
Active, Not Recruiting
|
NCT00268749
|
2002-07-01 |
Glycine Treatment of Prodromal Symptoms
|
Phase 2
|
Completed
|
NCT00005658
|
2000-05-01 |
Glycine to Treat Psychotic Disorders in Children
|
Phase 2
|
Completed
|
NCT00222235
|
2000-01-01 |
Adjunctive Treatment for Decreasing Symptoms of Schizophrenia
|
Phase 2/Phase 3
|
Completed
|
NCT00000372
|
1998-03-01 |
Glycine and D-Cycloserine in Schizophrenia
|
Phase 3
|
Withdrawn
|